Benchmark analyst Robert Wasserman downgrades Danaher (NYSE:DHR) from Buy to Hold.
Why Northern Trust Shares Are Diving Today
Northern Trust Corp (NASDAQ: NTRS) shares are trading lower by over 6% after the
Benchmark Downgrades Danaher to Hold
Benchmark analyst Robert Wasserman downgrades Danaher (NYSE:DHR) from Buy to Hold.
Related Posts
Immatics Biotechnologies Granted U.S. Patent #11648276: Immunotherapy against neuronal and brain tumors; #11648292: Immunotherapy against several tumors including gastrointestinal and gastric cancer
US 11648276 B2
Abstract
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of
NextGen Healthcare Announces Intention To Become A Qualified Health Information Network
NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced that it will apply to become a Qualified Health Information Network (QHIN) under the
Wells Fargo Upgrades Blueprint Medicines to Equal-Weight, Announces $41 Price Target
Wells Fargo analyst Derek Archila upgrades Blueprint Medicines (NASDAQ:BPMC) from Underweight to Equal-Weight and announces $41 price target.